Literature DB >> 31465114

The Quality of Nursing Homes That Serve Patients With Human Immunodeficiency Virus.

David J Meyers1, Ira B Wilson1, Yoojin Lee1, Shubing Cai2, Susan C Miller1, Momotazur Rahman1.   

Abstract

BACKGROUND/
OBJECTIVES: As the national population of persons living with human immunodeficiency virus (HIV) ages, they will require greater postacute and long-term care use. Little is known about the quality of nursing homes (NHs) to which patients with HIV are admitted. In this study, we assess the association between the number of persons with HIV admitted annually to a given NH (HIV concentration) and that NH's quality outcomes.
DESIGN: A cross-sectional comparative study.
SETTING: NHs in nine states, from 2001 to 2012. PARTICIPANTS: A total of 46 918 NH-years accounting for 67 301 admissions by patients with HIV. MEASUREMENTS: We used 100% Medicaid Analytic Extract, Minimum Dataset 2.0 and 3.0, and Medicare claims from 2001 to 2012 from nine states to examine the association between HIV concentration and NH quality. Persons were classified as HIV positive on the basis of all available data sources, and a NH's percentage of new admissions with HIV was calculated (HIV concentration). We then compared differences in star ratings, rehospitalization rates, NH survey deficiencies, and restraint use by a NH's percentage of admissions with HIV, using linear random effects models.
RESULTS: After adjusting for NH characteristics, zip code characteristics, and state and year fixed effects, NHs with greater than 0% to 5% of admissions with HIV had a 0.6 lower star rating (P < .001), and a 0.4% percentage point higher 30-day rehospitalization rate (P < .01), compared to those with no HIV admissions. NHs with 5% to 50% of admissions with HIV had 7.0 more deficiencies (P < .001), a 0.1 lower star rating (P < .001), and a 1.5 percentage point higher rehospitalization rate (P < .001).
CONCLUSION: Persons with HIV were generally admitted to lower-quality NHs compared to persons without HIV. More efforts are needed to ensure that persons with HIV have access to high-quality NHs. J Am Geriatr Soc 67:2615-2621, 2019.
© 2019 The American Geriatrics Society.

Entities:  

Keywords:  GINI coefficient; human immunodeficiency virus; nursing home quality

Mesh:

Year:  2019        PMID: 31465114      PMCID: PMC7227799          DOI: 10.1111/jgs.16155

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  20 in total

1.  Ten-year trends in antiretroviral therapy persistence among US Medicaid beneficiaries.

Authors:  Bora Youn; Theresa I Shireman; Yoojin Lee; Omar Galárraga; Aadia I Rana; Amy C Justice; Ira B Wilson
Journal:  AIDS       Date:  2017-07-31       Impact factor: 4.177

2.  The Care Span: Growth of racial and ethnic minorities in US nursing homes driven by demographics and possible disparities in options.

Authors:  Zhanlian Feng; Mary L Fennell; Denise A Tyler; Melissa Clark; Vincent Mor
Journal:  Health Aff (Millwood)       Date:  2011-07       Impact factor: 6.301

3.  HIV as a chronic disease: implications for long-term care at an AIDS-dedicated skilled nursing facility.

Authors:  P A Selwyn; J L Goulet; S Molde; J Constantino; K P Fennie; P Wetherill; D M Gaughan; H Brett-Smith; C Kennedy
Journal:  J Urban Health       Date:  2000-06       Impact factor: 3.671

4.  Are dual eligibles admitted to poorer quality skilled nursing facilities?

Authors:  Momotazur Rahman; David C Grabowski; Pedro L Gozalo; Kali S Thomas; Vincent Mor
Journal:  Health Serv Res       Date:  2013-12-19       Impact factor: 3.402

5.  HIV and aging: time for a new paradigm.

Authors:  Amy C Justice
Journal:  Curr HIV/AIDS Rep       Date:  2010-05       Impact factor: 5.071

6.  Sensitivity and specificity of the Minimum Data Set 3.0 discharge data relative to Medicare claims.

Authors:  Momotazur Rahman; Denise Tyler; Joseph Kofi Acquah; Julie Lima; Vincent Mor
Journal:  J Am Med Dir Assoc       Date:  2014-08-30       Impact factor: 4.669

7.  Analyses of nursing home residents with human immunodeficiency virus and depression using the minimum data set.

Authors:  Robert J Buchanan; Suojin Wang; Chunfeng Huang
Journal:  AIDS Patient Care STDS       Date:  2002-09       Impact factor: 5.078

8.  Temporal and Geographic variation in the validity and internal consistency of the Nursing Home Resident Assessment Minimum Data Set 2.0.

Authors:  Vincent Mor; Orna Intrator; Mark Aaron Unruh; Shubing Cai
Journal:  BMC Health Serv Res       Date:  2011-04-15       Impact factor: 2.655

9.  Trajectory of Physical Functioning Among Persons Living With HIV in Nursing Homes.

Authors:  Shubing Cai; Susan C Miller; Ira B Wilson
Journal:  J Am Med Dir Assoc       Date:  2019-03-04       Impact factor: 7.802

10.  Nursing Home Residents by Human Immunodeficiency Virus Status: Characteristics, Dementia Diagnoses, and Antipsychotic Use.

Authors:  Susan C Miller; Shubing Cai; Lori A Daiello; Theresa I Shireman; Ira B Wilson
Journal:  J Am Geriatr Soc       Date:  2019-05-07       Impact factor: 7.538

View more
  4 in total

1.  Assessing the Quality of Human Immunodeficiency Virus Care in Nursing Homes.

Authors:  Brianne Olivieri-Mui; Jean McGuire; John Griffith; Sean Cahill; Becky Briesacher
Journal:  J Am Geriatr Soc       Date:  2020-02-13       Impact factor: 5.562

2.  Economic Barriers to Antiretroviral Therapy in Nursing Homes.

Authors:  Brianne L Olivieri-Mui; Benjamin Koethe; Becky Briesacher
Journal:  J Am Geriatr Soc       Date:  2019-12-12       Impact factor: 5.562

3.  Hip Fracture Rates in Nursing Home Residents With and Without HIV.

Authors:  Tingting Zhang; Ira B Wilson; Andrew R Zullo; David J Meyers; Yoojin Lee; Lori A Daiello; Dae Hyun Kim; Douglas P Kiel; Theresa I Shireman; Sarah D Berry
Journal:  J Am Med Dir Assoc       Date:  2021-09-25       Impact factor: 7.802

4.  Understanding the Relationship Between Nursing Home Experience With Human Immunodeficiency Virus and Patient Outcomes.

Authors:  David J Meyers; Ira B Wilson; Yoojin Lee; Momotazur Rahman
Journal:  Med Care       Date:  2021-01       Impact factor: 3.178

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.